Clinical trial
A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral…
NCT00153842 · Dartmouth-Hitchcock Medical Center, Other · Terminated
Key facts
| NCT number | NCT00153842 |
|---|---|
| Title | A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer |
| Official title | Phase I and II Clinical Studies of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules for the Treatment of Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | Bristol-Myers Squibb Industry Ligand Pharmaceuticals |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-small-cell Lung |
| Intervention type | Drug |
| Interventions | Bexarotene (targretin) |
| Enrollment | 33 |
| Start date | Aug 1, 2001 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 6, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: